Logistics drones in medical biology: issues and challenges

[ad_1]

Cerba HealthCare and The Drone Office have published a white paper which analyzes the issues and challenges of drones in support of the logistics of medical biology samples. Presentation.

Innovation in medical biology is fueled by scientific and technical progress in its core business, including the logistics of sampling. However, the emergence of autonomous vehicles suggests a transformation in transport and logistics. Google cars, Hyperloop trains, in Amazon Prime Air, Google Wings, taxi cabs … Science fiction or reality?

The first experiments with delivery by aerial drones have started in the medical field. Unicef ​​in particular supports drone delivery projects of blood bags and vaccines in countries where infrastructure is weak or non-existent.

The Cerba HealthCare and The Drone Office teams took stock of the current and future possibilities offered by drones in medical biology and they analyzed 4 concrete use cases where the aerial drone would complement existing logistic schemes:

  • Offer an emergency service 24/7, especially in Europe

  • Improving cervical cancer screening in sub-Saharan Africa

  • Better serve remote industrial sites

  • Overcome traffic jams in saturated mega-cities.

" We are very pleased to collaborate with Cerba HealthCare on use cases that could concretely improve the medical biology service for the benefit of patients and doctors, and to identify the conditions of their exploitation in technological, regulatory and economic terms. The challenge is immense and exciting Says Anne-Lise Scaillierez, partner of The Drone Office.

" Through this partnership with The Drone Office, we are pursuing our Open Innovation strategy consisting in early identification of technological developments in all of our businesses and in supporting innovative start-ups in their development "Said Jérôme Sallette, Director of Innovation and Development at Cerba HealthCare.

Source: Cerba HealthCare

M-health Smart health articles

[ad_2]